Niklas Loman
Lund University(SE)
Publications by Year
Research Areas
BRCA gene mutations in cancer, Cancer Genomics and Diagnostics, DNA Repair Mechanisms, Ovarian cancer diagnosis and treatment, Genomic variations and chromosomal abnormalities
Most-Cited Works
- → Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies(2003)3,661 cited
- → Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial(2010)2,279 cited
- → Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation(2014)1,667 cited
- → An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression(2017)520 cited
- → Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer(2015)494 cited
- → Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer(2022)414 cited
- → Efficacy and safety of olaparib monotherapy in germline BRCA1 / 2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy(2015)298 cited
- → Family History of Breast and Ovarian Cancers and BRCA1 and BRCA2 Mutations in a Population-Based Series of Early-Onset Breast Cancer(2001)249 cited
- → Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial(2013)234 cited
- → Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics(2010)194 cited